These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8950699)

  • 1. Effect of aluminium on expression and processing of amyloid precursor protein.
    Neill D; Leake A; Hughes D; Keith AB; Taylor GA; Allsop D; Rima BK; Morris C; Candy JM; Edwardson JA
    J Neurosci Res; 1996 Nov; 46(4):395-403. PubMed ID: 8950699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research.
    Neill D; Hughes D; Edwardson JA; Rima BK; Allsop D
    J Neurosci Res; 1994 Nov; 39(4):482-93. PubMed ID: 7884825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of FE65 Ser610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer's disease amyloid precursor protein processing.
    Chow WN; Ngo JC; Li W; Chen YW; Tam KM; Chan HY; Miller CC; Lau KF
    Biochem J; 2015 Sep; 470(3):303-17. PubMed ID: 26188042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.
    Morse LJ; Payton SM; Cuny GD; Rogers JT
    J Mol Neurosci; 2004; 24(1):129-36. PubMed ID: 15314261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
    Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
    Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability of beta-amyloid precursor protein in nine different cell types.
    Lahiri DK
    Biochem Mol Biol Int; 1993 Apr; 29(5):849-58. PubMed ID: 8508138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells.
    Latasa MJ; Belandia B; Pascual A
    Endocrinology; 1998 Jun; 139(6):2692-8. PubMed ID: 9607774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing.
    Yogev-Falach M; Bar-Am O; Amit T; Weinreb O; Youdim MB
    FASEB J; 2006 Oct; 20(12):2177-9. PubMed ID: 16935943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dinucleotide deletion in amyloid precursor protein (APP) mRNA associated with sporadic Alzheimer's disease results in efficient secretion of truncated APP isoforms from neuroblastoma cell cultures.
    Hersberger M; Santiago-Garcia J; Patarroyo-White S; Yan J; Xu X
    J Neurochem; 2001 Mar; 76(5):1308-14. PubMed ID: 11238715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APP gene family: unique age-associated changes in splicing of Alzheimer's betaA4-amyloid protein precursor.
    Sandbrink R; Masters CL; Beyreuther K
    Neurobiol Dis; 1994 Nov; 1(1-2):13-24. PubMed ID: 9216982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region.
    Ge YW; Ghosh C; Song W; Maloney B; Lahiri DK
    J Neurochem; 2004 Sep; 90(6):1432-44. PubMed ID: 15341527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of APP(SWE) transfection on nicotinic receptors in cultured neuronal cells].
    An Y; Tang Z; Qi XL; Xiao Y; Shan KR; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):48-51. PubMed ID: 20388400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
    Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
    Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
    Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
    Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cholinergic agonist carbachol reduces intracellular beta-amyloid precursor protein in PC 12 and C6 cells.
    Lahiri DK; Nall C; Farlow MR
    Biochem Int; 1992 Dec; 28(5):853-60. PubMed ID: 1288495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
    Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
    J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.